|
|
Volumn 75, Issue 6, 2001, Pages 1106-1110
|
|
Recombinant or urinary follicle-stimulating hormone? A cost-effectiveness analysis derived by particularizing the number needed to treat from a published meta-analysis
a
|
|
Author keywords
Budget impact analyses; Cost needed to treat; Follicle stimulating hormones; ICSI; Incremental cost effectiveness ratio; IVF; Number needed to treat
|
|
Indexed keywords
HORMONE DERIVATIVE;
RECOMBINANT FOLLITROPIN;
UROFOLLITROPIN;
AGE;
ARTICLE;
CLINICAL TRIAL;
CONTRACEPTION;
COST EFFECTIVENESS ANALYSIS;
DRUG COST;
FERTILIZATION IN VITRO;
HUMAN;
INTRACYTOPLASMIC SPERM INJECTION;
META ANALYSIS;
PREGNANCY RATE;
PRIORITY JOURNAL;
RETROSPECTIVE STUDY;
SUPEROVULATION;
UNITED KINGDOM;
ADULT;
AGING;
BUDGETS;
COST-BENEFIT ANALYSIS;
FEMALE;
FERTILIZATION IN VITRO;
FOLLICLE STIMULATING HORMONE;
HEALTH CARE COSTS;
HUMANS;
MALE;
META-ANALYSIS;
PREGNANCY;
PREGNANCY RATE;
RECOMBINANT PROTEINS;
RETROSPECTIVE STUDIES;
SPERM INJECTIONS, INTRACYTOPLASMIC;
|
|
EID: 0034994279
PISSN: 00150282
EISSN: None
Source Type: Journal
DOI: 10.1016/S0015-0282(01)01808-8 Document Type: Article |
|
Times cited : (7)
|
|
References (9)
|
